Last updated: 2026-11-13 14:12:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Hims & Hers Health, Inc. (HIMS) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NYSE. The stock is currently priced at $19.95, with a market capitalization of $4.62B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.74 to $40.99. This page covers its latest market performance, valuation, price trends and company information.
$4.62B | |
$19.82 | |
$20.13 | |
$19.57 | |
$19.73 | |
224.87K | |
11.94M | |
-- | |
$40.99 | |
$13.74 | |
-- | |
12-31 |
Hims & Hers Health, Inc. (HIMS) is trading at $19.95 in pre-market trading as of 2026-11-13 14:11:00, up 1.12% ($0.22) from the previous close of $19.73
Pre-market trading shows how investors are pricing HIMS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Hims & Hers Health, Inc. (HIMS) moved from $24.06 to $19.95, representing a decline of 17.08% ($4.11).
The stock traded between $18.40 and $26.57 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 25.31 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 22.8%
HIMS is currently trading at $19.95, placing it 22.8% of the way from its 52-week low of $13.74 to its 52-week high of $40.99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2.7 million subscribers, is available in all 50 states and certain international markets including the UK, Germany, and Australia. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 2,442 |
| CEO | Andrew Dudum |
| Founded | 2017 |
| Exchange | NYSE |
| Company Website |
Latest news related to Hims & Hers Health, Inc. and HIMS stock.
Hims & Hers (HIMS) reported Q3 2026 EPS of 3 cents, missing estimates by 57.1%, though revenues grew 48.7% year-over-year to $890.4 million. The company faced margin compression due to lower-margin weight loss products and a sequential subscriber decline of 100,000. HIMS lowered its full-year adjusted EBITDA guidance to $257-$277 million but raised international revenue outlook to at least $650 million.
The global telehealth market is experiencing significant growth, projected to expand from $77.4 billion in 2025 to $187.5 billion by 2033. Key developments include AI-powered diagnostics, remote patient monitoring, and virtual care expansion. Rocket Doctor AI joined the Altais network to expand telehealth services in California, while competitors like Teladoc Health, Amwell, Hims & Hers, and Doximity launched new AI capabilities and research initiatives to enhance digital healthcare delivery.
Eligible investors can buy real shares of Hims & Hers Health, Inc. (HIMS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Browse other US stocks in the same sector as Hims & Hers Health, Inc.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HIMS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HIMS shares and USD.
HIMS Shares to USD
1.00 HIMS shares = 19.95 USD
Calculations are estimates based on the latest available price and are for reference only.
